Recent News

522 News Items found
Pictured: Eric C. Holland
Researchers Discover Genetic Changes That Make Some Forms of Brain Cancer More Aggressive Than Others
A multi-institutional team led by investigators from Memorial Sloan Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies.
Study Answers Important Question about Using Carbon Nanotubes in Medicine
A multicenter study led by Memorial Sloan Kettering researchers has answered an important question about the safety of using carbon nanotubes in medicine.
2010 Shaps Scholars
Four summer students -- Jeannie Camarillo, Emily Grzybowski, Nathaniel Kim, and Daniel Triner -- were named 2010 Rubin and Sarah Shaps Scholars.
Boris Bastian
Boris Bastian Named Chair of the Department of Pathology
Physician-scientist Boris C. Bastian joined Memorial Sloan Kettering as Attending Physician and Chair of the Department of Pathology on April 1.
Harold Varmus former CEO of MSK
Harold Varmus: A Decade of Leadership at MSK
Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute.
Inherited Mutations May Point to an Aggressive Form of Prostate Cancer
A team of Memorial Sloan Kettering researchers reports that prostate cancer often takes an aggressive course in patients who have inherited mutations in the genes <i>BRCA1</i> or <i>BRCA2</i>.
Ingo Mellinghoff
Researchers Uncover Molecular Interactions in Common Form of Brain Cancer
A multicenter team led by Memorial Sloan Kettering neurologist and researcher Ingo K. Mellinghoff has uncovered the relationship between two proteins that play a critical role in glioblastoma, the most common form of brain cancer.
Charles Sawyers
Large-Scale Genomic Analysis of Prostate Cancer Unveiled
A unique collaboration among physician-scientists at Memorial Sloan Kettering Cancer Center has yielded the most comprehensive genomic analysis of prostate cancer to date. The study, published in the journal <I>Cancer Cell</I>, provides a previously unavailable genomic analysis whose scope and size offers new insight leading to more effective diagnostic tests as well as future treatment options for prostate cancer patients.
Charles Sawyers
Charles Sawyers Elected to the National Academy of Sciences
Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, was elected to the National Academy of Sciences at the group's 147th annual meeting in April.
Rendering of a primary tumor mass with adjoining blood vessels (shown in red). Cells that have detached from the tumor and entered the bloodstream (shown as spheres) may circle back to the tumor and enhance its growth and aggressiveness.
Circulating Tumor Cells May Spur Cancer by a Previously Unknown Mechanism
A recent Memorial Sloan Kettering study shows that some circulating tumor cells can circle back and infiltrate their tumor of origin, enhancing its growth and aggressiveness.